This delivery system was found to effectively suppress breast cancer bone metastasis via the synergistic function of sorafenib which suppresses SLC7A11, and photodynamic therapy induced by 660 nm laser which increases ROS level. This evidence concerns the gene SLC7A11 and breast carcinoma.